-13.
-
.
Healy:
(a) The methodology
of converting
IMP data to pr/hr and then to rads
at 1 foot height should be in the July 15 paper.
(b) Looks like you are ignoring everything
inhaled except the
respirable part.
Robison:
No!
We use the entire inhaled material.
Healy:
A..
(c) Doses from ‘4iPu should be in the dose assessment
Robison:
These data aren’t available yet from Eberline and DRI.
from 241 Puwill
Healy:
(d)
paper.
The dose
be very small.
Ingestion.
There are no data in present LLL draft giving
pCi/g concentrations
for diet (animals, marine).
Be sure that in the report you say what you have done and where
the data come from.
Robison:
How do we generalize animal data to other animals?
Healy:
Would like some discussion of dose models themselves
in the
dose paper.
McClellan:
Robison should write a better introduction which includes a general
outline of how the dose assessment was done.
of detail:
(in”mainbody
(1) general description
There are three levels
of how doses were estimated
of the report), (2) a very detailed description
including equations
(in appendix) and (3) worked examples
(in appendix).
Bai r:
You must also give limitations
Templeton:
You must consider the case of children playing in the dust.
Robison:
Doesn’t know how to handle estimating
Healy:
Does Spiers modeling approach for Sr-90 apply to children?
and assumptions.
doses for this case.
*